<!doctype html>
<html lang="en" class="no-js">
<head>
  <meta charset="utf-8">
  <title>DAA trends</title>
  <link rel="stylesheet" href="../assets/css/main.css">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@latest/css/all.min.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
</head>
<body class="layout--home">
  <div class="masthead">
    <div class="masthead__menu">
      <nav class="site-nav">
        <ul>
          <li class="masthead__menu-item"><a href="../index.html">Summary</a></li>
          <li class="masthead__menu-item"><a href="daa-trends.html">DAA trends</a></li>
          <li class="masthead__menu-item"><a href="retreatment-trends.html">Retreatment trends</a></li>
          <li class="masthead__menu-item"><a href="population-trends.html">Population trends</a></li>
          <li class="masthead__menu-item"><a href="prescriber-trends.html">Prescriber trends</a></li>
          <li class="masthead__menu-item"><a href="state-trends.html">State and Territory trends</a></li>
          <li class="masthead__menu-item"><a href="methods.html">Methodology</a></li>
        </ul>
      </nav>
    </div>
  </div>
  <div class="masthead__inner-wrap"></div>
  <div class="initial-content">
    <div id="main" role="main">
      <div class="archive">
        <h2 class="archive__title">Retreatment trends</h2>
        <h3 class="archive__subtitle">Retreatment</h3>
        <p>Of 13456 retreatments occurring during 2016 to 2023, 60% (n=8012) were estimated for reinfection and 40% (n=5453) 
            for treatment failure. Quarterly trends in retreatments for reinfection and treatment failure are illustrated in 
            <strong> Figure 3. </strong> </p>
    
        <div class="plot-container">
        <iframe src="../plotly/F03.html" width="700" height="500" frameborder="0" allowfullscreen></iframe>
        </div>
        <h3 class="archive__subtitle">Retreatment for treatment failure</h3>
        <p>The number of retreatment initiations for treatment failure increased between the first and second quarters of 2019, 
            corresponding to when sofosbuvir/velpatasvir/voxilaprevir was listed on the PBS in April 2019. Since 2021, the trend 
            in number of retreatments for treatment failure has stabilised. The number of retreatments for treatment failure was
             605 in 2023, increasing to 705 in 2023. Numbers of retreatments and multiple treatments for treatment failure are 
             illustrated in <strong>Figure 4A.</strong></p>
        <div class="plot-container">
          <iframe src="../plotly/F04A.html" width="650" height="450" frameborder="0" allowfullscreen></iframe>
        </div>
        <h3 class="archive__subtitle">Retreatment for reinfection</h3>
        <p>An increasing trend in retreatments for reinfection was observed. The deceleration in retreatment for reinfection during 
            2020-2021 was followed by a distinct acceleration from 2022. The recent increases in retreatment for reinfection may be 
            due to increased HCV testing and detection following COVID-19 restrictions. Numbers of retreatments and multiple retreatments 
            for reinfection are illustrated in <strong>Figure 4.</strong></p>
        <div class="plot-container">
          <iframe src="../plotly/F04B.html" width="650" height="450" frameborder="0" allowfullscreen></iframe>
        </div>
      </div>       
    </div>
    <div class="page__footer">
      <footer>
        <div class="page__footer-follow social-icons">
          <a class="btn--linkedin" href="https://www.linkedin.com/in/joanne-carson-b320a527b" target="_blank">
            <i class="fab fa-linkedin-in"></i>
          </a>
          <a class="btn--github" href="https://github.com/jojocarson" target="_blank">
            <i class="fab fa-github"></i>
          </a>
          <p></p> 
        </div>
        <div class="page__footer-copyright">
          <a href="https://www.kirby.unsw.edu.au/research/reports/monitoring-hepatitis-c-treatment-uptake-australia-issue-14-july-2024">
            <strong>Reference for citations:</strong> Carson JM et al. Monitoring hepatitis C treatment uptake in Australia (Issue 14). <br> 
            The Kirby Institute, UNSW, Sydney NSW, Australia, July 2024 DOI: http://doi.org/10.26190/unsworks/30340
          </a>
        </div>
      </footer>
    </div>
  </div>
  <script src="../assets/js/main.min.js"></script>
</body>
</html>

